openPR Logo
Press release

Investigation announced for Long-Term Investors in Rain Oncology Inc. (NASDAQ: RAIN) over potential Wrongdoing

10-11-2023 06:14 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Rain Oncology Inc. (NASDAQ: RAIN) shares.

An investigation on behalf of current long term investors in Rain Oncology Inc. (NASDAQ: RAIN) shares.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Rain Oncology Inc..

Investors who are current long term investors in Rain Oncology Inc. (NASDAQ: RAIN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: RAIN stocks follows a lawsuit filed against Rain Oncology Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: RAIN stocks, concerns whether certain Rain Oncology Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that the Company concealed risks inherent in the design of its Phase 3 MANTRA study particularly with regard to proceeding directly to Phase 3 from Phase 1; and that as a result, the Company's statements about the trial and the likelihood of FDA approval were materially misleading between July 20, 2021 to May 19, 2023.

Those who purchased shares of Rain Oncology Inc. (NASDAQ: RAIN) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in Rain Oncology Inc. (NASDAQ: RAIN) over potential Wrongdoing here

News-ID: 3244371 • Views:

More Releases from Shareholders Foundation

Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: JHX) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT)
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc. Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Rain

03-19-2025 | Health & Medicine
Getnews
Preservative-Free Rain Eye Drops by RAIN, a Vision Health Brand, Now Available o …
Image: https://www.globalnewslines.com/uploads/2025/03/1742408542.jpg Innovative lubricant eye drops offer relief for dry and sensitive eyes LAS VEGAS - March 19, 2025 - RAIN, a vision health company, today announced that its preservative-free Rain Trademark Eye Drops, which help provide daily comfort for dry and sensitive eyes, are now available on the Walmart Marketplace. Designed for severe dry eye comfort, Rain Eye Drops offers a clean and gentle alternative to many legacy brands of
Rain Trading Limited (Rain ADGM) Renews Partnership with Notabene to Strengthen …
Image: https://www.getnews.info/wp-content/uploads/2024/07/1721078451.png Abu Dhabi, United Arab Emirates - July 30, 2024 - Rain Trading Limited (Rain ADGM) is pleased to announce the renewal of its partnership with Notabene, the industry leader in pre-transaction compliance solutions for the virtual assets sector. Known for its leadership in Travel Rule compliance within the region, Rain ADGM offers a reliable and secure platform for institutional and retail clients in the UAE to purchase, trade, and
Deadline on September 12th coming up in Lawsuit for Investors in Rain Oncology I …
A deadline is coming up on September 12, 2023 in the lawsuit filed for certain investors of Rain Oncology Inc. (NASDAQ: RAIN) over alleged securities laws violations by Rain Oncology Inc. (NASDAQ: RAIN). Investors who purchased shares of Rain Oncology Inc. (NASDAQ: RAIN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2023. NASDAQ: RAIN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Lawsuit filed for Investors who lost money with shares of Rain Oncology Inc. (NA …
An investor, who purchased shares of Rain Oncology Inc. (NASDAQ: RAIN), filed a lawsuit over alleged violations of Federal Securities Laws by Rain Oncology Inc. Investors who purchased shares of Rain Oncology Inc. (NASDAQ: RAIN) have certain options and for certain investors are short and strict deadlines running. Deadline: September 12, 2023. Rain Oncology Inc. (NASDAQ: RAIN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Newark,
Investigation announced for Investors in shares of Rain Oncology Inc. (NASDAQ: R …
An investigation was announced over potential securities laws violations by Rain Oncology Inc. in connection with certain financial statements. Investors who purchased shares of Rain Oncology Inc. (NASDAQ: RAIN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Rain Oncology Inc. regarding its business, its prospects and its operations were
Global Halal Bodywash Market 2017 : Aveeno, Tom’s of Maine, White Rain, Clara …
A market study based on the "Halal Bodywash Market" across the globe, recently added to the repository of Market Research, is titled ‘Global Halal Bodywash Market 2017’. The research report analyses the historical as well as present performance of the worldwide Halal Bodywash industry, and makes predictions on the future status of Halal Bodywash market on the basis of this analysis. Get Free Sample Copy of Report Here : http://bit.ly/2nmLXrM Top Manufacturers